Castle Biosciences Cash from Financing (Quarterly) Trends

Castle Biosciences Inc (CSTL)

22.02 +0.92 (+4.36%) USD | NASDAQ | May 01, 16:00

22.02 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	-3.297M
September 30, 2023	0.045M
June 30, 2023	0.226M
March 31, 2023	0.728M
December 31, 2022	-0.75M
September 30, 2022	0.388M
June 30, 2022	0.661M
March 31, 2022	1.216M
December 31, 2021	0.126M
September 30, 2021	1.894M
June 30, 2021	1.891M
March 31, 2021	1.51M

Date	Value
December 31, 2020	227.82M
September 30, 2020	8.15M
June 30, 2020	69.36M
March 31, 2020	0.559M
December 31, 2019	0.224M
September 30, 2019	76.42M
June 30, 2019	0.936M
March 31, 2019	10.71M
December 31, 2018	4.419M
September 30, 2018	0.0366M
June 30, 2018	6.035M
March 31, 2018	5.348M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-3.297M

Minimum

Dec 2023

227.82M

Maximum

Dec 2020

20.43M

Average

0.728M

Median

Mar 2023

Cash from Financing (Quarterly) Benchmarks

Exact Sciences Corp	10.04M
Illumina Inc	-27.00M
Mettler-Toledo International Inc	-248.97M
Waters Corp	-130.49M
Natera Inc	6.845M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	18.59M
Cash from Investing (Quarterly)	-7.672M
Free Cash Flow	-19.25M
Free Cash Flow Per Share (Quarterly)	0.5473
Free Cash Flow to Equity (Quarterly)	14.79M
Free Cash Flow to Firm (Quarterly)	14.79M
Free Cash Flow Yield	-3.26%